Long-Term Efficacy of Intravesical Bacillus Calmette-Guerin for Carcinoma in Situ: Relationship of Progression to Histological Response and p53 Nuclear Accumulation-Reference-Cited by-同舟云学术

Long-Term Efficacy of Intravesical Bacillus Calmette-Guerin for Carcinoma in Situ: Relationship of Progression to Histological Response and p53 Nuclear Accumulation

Published:1997-05 Issue:5 Volume:157 Page:1655-1659
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ovesen Henrik¹,Horn Thomas¹,Steven Kenneth¹

Affiliation:

1. From the Departments of Urology and Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ;Althausen;J. Urol.,1976

2. The outcome of conservative treatment of carcinoma in situ of the bladder;Prout;J. Urol.,1987

3. Outcome in carcinoma in situ of bladder treated with intravesical bacille Calmette-Guerin;Harland;Brit. J. Urol.,1992

4. Intravesical Evans bacille Calmette-Guerin in the treatment of carcinoma in situ;Cumming;Brit. J. Urol.,1989

5. Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup;Herr;J. Urol.,1992

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic models to help predict patient responses to intravesical immunotherapy;Expert Review of Precision Medicine and Drug Development;2020-06-01

2. Predictors of Response to Intravesical Therapy;Urologic Clinics of North America;2020-02

3. T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate;Translational Andrology and Urology;2018-12

4. Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review;European Urology;2018-05

5. Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer;Bladder Cancer;2018